IBDEI0J3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8342,0)
 ;;=B02.9^^65^533^2
 ;;^UTILITY(U,$J,358.3,8342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8342,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,8342,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,8342,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,8343,0)
 ;;=Z91.5^^65^534^1
 ;;^UTILITY(U,$J,358.3,8343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8343,1,3,0)
 ;;=3^Personal Hx of Suicide Attempt(s)
 ;;^UTILITY(U,$J,358.3,8343,1,4,0)
 ;;=4^Z91.5
 ;;^UTILITY(U,$J,358.3,8343,2)
 ;;=^5063624
 ;;^UTILITY(U,$J,358.3,8344,0)
 ;;=R45.851^^65^534^2
 ;;^UTILITY(U,$J,358.3,8344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8344,1,3,0)
 ;;=3^Suicidal Ideations
 ;;^UTILITY(U,$J,358.3,8344,1,4,0)
 ;;=4^R45.851
 ;;^UTILITY(U,$J,358.3,8344,2)
 ;;=^5019474
 ;;^UTILITY(U,$J,358.3,8345,0)
 ;;=T14.91XA^^65^534^3
 ;;^UTILITY(U,$J,358.3,8345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8345,1,3,0)
 ;;=3^Suicide Attempt,Initial Encntr
 ;;^UTILITY(U,$J,358.3,8345,1,4,0)
 ;;=4^T14.91XA
 ;;^UTILITY(U,$J,358.3,8345,2)
 ;;=^5151779
 ;;^UTILITY(U,$J,358.3,8346,0)
 ;;=T14.91XD^^65^534^4
 ;;^UTILITY(U,$J,358.3,8346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8346,1,3,0)
 ;;=3^Suicide Attempt,Subsequent Encntr
 ;;^UTILITY(U,$J,358.3,8346,1,4,0)
 ;;=4^T14.91XD
 ;;^UTILITY(U,$J,358.3,8346,2)
 ;;=^5151780
 ;;^UTILITY(U,$J,358.3,8347,0)
 ;;=T14.91XS^^65^534^5
 ;;^UTILITY(U,$J,358.3,8347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8347,1,3,0)
 ;;=3^Suicide Attempt,Sequela
 ;;^UTILITY(U,$J,358.3,8347,1,4,0)
 ;;=4^T14.91XS
 ;;^UTILITY(U,$J,358.3,8347,2)
 ;;=^5151781
 ;;^UTILITY(U,$J,358.3,8348,0)
 ;;=11000^^66^535^1^^^^1
 ;;^UTILITY(U,$J,358.3,8348,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8348,1,2,0)
 ;;=2^11000
 ;;^UTILITY(U,$J,358.3,8348,1,3,0)
 ;;=3^Debride ext eczematous skin,<10%
 ;;^UTILITY(U,$J,358.3,8349,0)
 ;;=11001^^66^535^2^^^^1
 ;;^UTILITY(U,$J,358.3,8349,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8349,1,2,0)
 ;;=2^11001
 ;;^UTILITY(U,$J,358.3,8349,1,3,0)
 ;;=3^Debride ext eczematous skin,Ea 10%
 ;;^UTILITY(U,$J,358.3,8350,0)
 ;;=11042^^66^535^3^^^^1
 ;;^UTILITY(U,$J,358.3,8350,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8350,1,2,0)
 ;;=2^11042
 ;;^UTILITY(U,$J,358.3,8350,1,3,0)
 ;;=3^Debride Subcut (epi/derm);20sq cm or <
 ;;^UTILITY(U,$J,358.3,8351,0)
 ;;=11045^^66^535^4^^^^1
 ;;^UTILITY(U,$J,358.3,8351,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8351,1,2,0)
 ;;=2^11045
 ;;^UTILITY(U,$J,358.3,8351,1,3,0)
 ;;=3^Debride Subcut (epi/derm);Ea Addl 20sq cm
 ;;^UTILITY(U,$J,358.3,8352,0)
 ;;=17000^^66^536^7^^^^1
 ;;^UTILITY(U,$J,358.3,8352,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8352,1,2,0)
 ;;=2^17000
 ;;^UTILITY(U,$J,358.3,8352,1,3,0)
 ;;=3^Destroy 1st Premalignant Lesion
 ;;^UTILITY(U,$J,358.3,8353,0)
 ;;=17004^^66^536^6^^^^1
 ;;^UTILITY(U,$J,358.3,8353,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8353,1,2,0)
 ;;=2^17004
 ;;^UTILITY(U,$J,358.3,8353,1,3,0)
 ;;=3^Destroy 15+ Premalignant Lesions
 ;;^UTILITY(U,$J,358.3,8354,0)
 ;;=17110^^66^536^4^^^^1
 ;;^UTILITY(U,$J,358.3,8354,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8354,1,2,0)
 ;;=2^17110
 ;;^UTILITY(U,$J,358.3,8354,1,3,0)
 ;;=3^Destroy 1-14 Benign Lesions
 ;;^UTILITY(U,$J,358.3,8355,0)
 ;;=17111^^66^536^5^^^^1
 ;;^UTILITY(U,$J,358.3,8355,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,8355,1,2,0)
 ;;=2^17111
 ;;^UTILITY(U,$J,358.3,8355,1,3,0)
 ;;=3^Destroy 15+ Benign Lesions
